Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +0.35% | +8.27% | +15.20% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.20% | 38.36M | |
+3.47% | 108B | |
+11.05% | 104B | |
+1.28% | 22.33B | |
-12.87% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.33% | 17.64B | |
+3.82% | 14.05B | |
+35.87% | 12.51B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Transcript : OncoCyte Corporation, Q3 2023 Earnings Call, Nov 09, 2023